Navigation Links
Generex Announces Sales Agreement with Elias Shaker & Company
Date:9/20/2010

WORCESTER, Mass., Sept. 20 /PRNewswire/ -- Generex Biotechnology Corporation (Nasdaq: GNBT), (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has entered into a sales agreement with Elias Shaker & Company (www.eliasshaker.com), a leading national full-service consumer product brokerage firm, to represent Generex's novel consumer products to national and regional retail and wholesale accounts in the USA.

Founded in 1924 by Elias Shaker, the company has established itself as a respected, quality-conscious, service-driven organization committed to producing measurable results.  Elias Shaker & Company has established relationships with all class of trades from national drug chains and wholesalers to mass merchandisers/club stores, grocery chains, food wholesalers, convenience stores and distributors and specialty stores, representing a total of more than 200,000 retail points of purchase throughout the USA.

"We are very excited to partner with an experienced and results-driven sales firm such as Elias Shaker to represent our proprietary consumer products in the USA," said Rose Perri, the Company's Chief Operating Officer.  "We welcome the opportunity to have our products showcased and represented by a company with an extensive history in retail."

"After reviewing Generex's consumer products, its current distribution and discussing it with our sales team internally we are very confident in taking their product-line to the next level by focusing on building new distribution, supporting established accounts and taking advantage of unique promotional opportunities that may arise which will ultimately grow brand awareness and sales," said Bruce Funk, Elias Shaker & Company's President.'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
2. Generex Announces Presentations of Novel Vaccine Strategies
3. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
4. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
5. PAREXEL Announces Strategic Functional Service Provider Relationship with Eli Lilly and Company for Clinical Development in Asia/Pacific Region
6. Nonin Medical Announces Continua™ Certified USB Data Transfer Device for Its Handheld Oximeter Line
7. Eddingpharm (Cayman) Inc. Announces Closing of Series B Funding
8. Alere Inc. Announces Pricing of Senior Subordinated Notes Offering; Offering Size Increased to $400.0 Million
9. Solta Medical Announces FDA 510(k) Clearance of Fraxel re:store Dual Laser System for the Treatment of Actinic Keratosis
10. LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results
11. PDL BioPharma Announces Retirement of $54.3 Million of 2.75% Convertible Notes Due 2023
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... VALLEY, Calif. , May 4, 2015 ... biologic for psoriasis, today announced that preclinical and mechanism ... session at the Society of Investigative Dermatology (SID) Annual ... Atlanta, in Atlanta, Georgia . ... is advancing the development of RON2315, a novel, low ...
(Date:5/4/2015)...   HeartWare International, Inc . (NASDAQ: HTWR ), ... that are revolutionizing the treatment of advanced heart failure, today ... scheduled to present at the Bank of America Merrill Lynch ... on Thursday, May 14, 2015, at 10:00 a.m. PT ... Company,s presentation at the conference will be available via a ...
(Date:5/4/2015)... , May 4, 2015 Unchained Labs, a ... to this year,s PEGS conference and launches the UNit ... for biologics. PEGS: The Essential Protein Engineering Summit takes ... 2015. The UNit lets drug discovery researchers ... tool out there. Its 7 applications, 144 sample a ...
Breaking Medicine Technology:Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2Unchained Labs Lets the UNit Loose 2
... Ambrx Inc. today announced that Ho Cho, Ph.D., ... from the company,s antibody drug conjugate (ADC) programs at ... obtained from recent xenograft studies comparing Ambrx ADCs with ... technology has been clinically validated as safe and efficacious ...
... 22, 2011 Naurex Inc., a clinical-stage ... psychiatry and neurology, today announced that it has initiated ... GLYX-13.  GLYX-13, a Glycine-site Functional Partial Agonist (GFPA) selective ... developed as a therapy for patients who are not ...
Cached Medicine Technology:Ambrx to Present Data from Antibody Drug Conjugate Program at Upcoming Scientific Conferences 2Naurex Initiates Phase II Clinical Trial of Novel Antidepressant GLYX-13 in Treatment-Resistant Depression 2Naurex Initiates Phase II Clinical Trial of Novel Antidepressant GLYX-13 in Treatment-Resistant Depression 3
(Date:5/4/2015)... Now in its seventh year, the IPC ... made outstanding contributions to the company, to their facilities ... and post-acute care settings. The five award categories are: ... Year, Advanced Practice Clinician of the Year, Newcomer Provider ... Recipients are selected by IPC’s senior management team. , ...
(Date:5/4/2015)... 04, 2015 EyeCRO LLC and NeuMedics ... facilitate development of NM108, a first-in-class small molecule to ... blindness, including Diabetic Retinopathy. The collaboration grants NeuMedics ... EyeCRO, which can deliver drugs to the front and ... , Under the terms of the agreement, EyeCRO will ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Ticket Down is ... the Colonial Life Arena in Columbia, South Carolina. ... continuation of his “Out There” tour which originally kicked off ... tour is North America and the legendary performer recently announced ... the Wells Fargo Arena on June 21st, in Charlottesville, VA ...
(Date:5/4/2015)... UT (PRWEB) May 04, 2015 Pricing ... (up to $3,000) of one patient receiving care at ... Utah. The procedure must be performed by July 15th, ... to pay in full up front and forego the filing ... becomes more economically burdensome every year, and it devastates more ...
(Date:5/4/2015)... Atlanta, GA (PRWEB) May 04, 2015 ... in Atlanta, Georgia proudly offers the latest non-surgical double-chin ... the only facial plastic surgeon in Atlanta to offer ... Kybella drug to be injected specifically under the chin, ... ‘double-chin’ appearance. , Before Kybella, patients who sought immediate ...
Breaking Medicine News(10 mins):Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3Health News:Facial Plastic Surgeon First in Atlanta To Offer Kybella Treatments To Reduce Chin Fat 2
... American Heart Association's online heart disease education program were ... reported at the American Heart Association's 8th Scientific ... Cardiovascular Disease and Stroke. ,Those who used ... program developed with Thomson Healthcare also were more ...
... have intensified monitoring of over 800 poultry farms in the ... farms there, an official said Saturday. ... farms May 22 and in two other farms the next ... reported, quoting Livestock Commissioner R.H Usmani. ,Several thousand ...
... persons attitude that determines how much exercise is too much ... Clinic. ,The researchers say that people who ... benefits it provides have the right reason in mind, but ... spite of injuries may be at a risk of developing ...
... the Blue Moon will be possible after midnight of June 1. ... full Moons occur within a calendar month, that the second full ... you live London, you will officially have to wait until June ... to astronomers and cosmologists, May 31 will brings us the second ...
... Pitt is enjoying parental bliss to the fullest. ... Pitt poured his heart out about the delight and joys of ... They're mind-blowing. Get ready to change no end of dirty diapers. ... ever happened to me,' the Mirror quoted Pitt, as saying. ...
... have discovered mutations in the DNA of four genes ... cancer in women . ,The discovery would ... higher-than-average risk of breast cancer so that they could ... the age when routine breast screening now begins. ...
Cached Medicine News:Health News:Online Education Program Better Source of Information for Patients 2Health News:Online Education Program Better Source of Information for Patients 3Health News:Attitude Determines How Much Exercise is too Much 2Health News:Blue Moon at Midnight from June 1 2Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 2Health News:UK Scientists Identify Gene Mutations That Trigger Breast Cancer 3
... Chart Manager information can be input ... are not limited to drop-down lists ... each person to document individually. Patient ... valuable data and communication. All this ...
AllMeds was the first specialty-specific Electronic Medical Record for Orthopaedics. Instead of trying to force a general-purpose EMR into your practice, AllMeds starts with clinical content from Ort...
... software It runs over hospital ... PAS systems and some items ... collects data at initial consultation, ... checks, operation, post-op checks, telephone ...
... such as prescription writing, referral letters, chart ... will be ,able to add more appointments ... staff., Based on the exam documentation created ... recommend the appropriate E&M ,code for the ...
Medicine Products: